Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy|
|Abstract:||The present invention relates to compounds being esters of 5-aminolevulinic acids or pharmaceutically acceptable salts thereof, including compounds of formula (I) R.sub.2.sup.2 N--CH.sub.2 COCH.sub.2 --CH.sub.2 CO--OR.sup.1 (wherein R.sup.1 may represent alkyl optionally substituted by hydroxy, alkoxy, acyloxy, alkoxycarbonyloxy, amino, aryl, oxo or fluoro groups and optionally interrupted by oxygen, nitrogen, sulphur or phosphorus atoms; and R.sup.2 represents a hydrogen atom or a group R.sup.1, and both R.sup.2 groups may be the identical or different), and their use in diagnosis and photochemotherapy of disorders or abnormalities of external or internal surfaces of the body, and products and kits for performing the invention.|
|Inventor(s):||Gierskcky; Karl E. (Oslo, NO), Moan; Johan (Oslo, NO), Peng; Qian (Oslo, NO), Steen; Harald (Oslo, NO), Warloe; Trond (Oslo, NO), Bjorseth; Alf (Oslo, NO)|
|Assignee:||PhotoCure AS (Oslo, NO)|
|Filing Date:||Dec 21, 1999|
|Claims:||1. A method for the diagnosis or photochemotherapeutic treatment of infections or skin disorders of the body, comprising: i) administering to the sites of investigation or affected surfaces of the body a composition comprising a compound of formula I |
wherein R.sup.1 is alkyl; and each R.sup.2 is independently hydrogen or alkyl; wherein each alkyl of R.sup.1 and R.sup.2 is optionally substituted by hydroxy, alkoxy, acyloxy, alkoxycarbonyloxy, amino, aryl, oxo or fluoro groups and is optionally interrupted by oxygen atoms; or a salt thereof; and ii) exposing said sites or surfaces to light.
2. The method of claim 1 wherein aryl is phenyl or a monocyclic 5-7 membered heteroaromatic.
3. The method of claim 1 wherein R.sup.1 represents an unsubstituted alkyl group and each R.sup.2 is hydrogen.
4. The method of claim 1 wherein R.sup.1 represents an unsubstituted alkyl group or each R.sup.2 is hydrogen.
5. The method of claim 1 wherein alkyl contains up to 10 carbon atoms.
6. The method of claim 1 wherein the compound is ALA-methyl ester, ALA-ethyl ester, ALA-propyl ester, ALA-hexyl ester, ALA-heptyl ester, or ALA-octyl ester; or a salt thereof.
7. The method of claim 1 wherein the light is in the wavelength region 500-700 nm.
8. The method of claim 1 wherein the skin disorder is psoriasis.
9. The method of claim 1 wherein the infection is a bacterial, viral or fungal infection.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.